Search for: "Lee v. Merck & Co Inc et al"
Results 1 - 17
of 17
Sorted by Relevance
|
Sort by Date
14 Nov 2016, 9:16 am
Petitions for Writ of Certiorari Pending: Anticipation/Obviousness: Merck & Cie, et al. v. [read post]
13 Oct 2016, 6:50 am
Post Grant Admin: Merck & Cie, et al. v. [read post]
28 Sep 2016, 8:39 am
Post Grant Admin: Merck & Cie, et al. v. [read post]
8 Feb 2017, 3:09 am
Amgen Inc., et al., No. 16-332 (effectively extending exclusivity to 12 1/2 years; complement to the Sandoz petition) Anticipation/Obviousness: Merck & Cie, et al. v. [read post]
16 Jan 2017, 5:44 pm
Amgen Inc., et al., No. 16-332 (effectively extending exclusivity to 12 1/2 years; complement to the Sandoz petition) Anticipation/Obviousness: Merck & Cie, et al. v. [read post]
5 Sep 2016, 6:46 pm
Post Grant Admin: Merck & Cie, et al. v. [read post]
18 Sep 2016, 6:03 pm
Post Grant Admin: Merck & Cie, et al. v. [read post]
27 Sep 2019, 2:49 am
”); Merck & Co. v. [read post]
9 Aug 2012, 5:00 am
Merck (Vioxx) Trial2006-05-08 Doherty v. [read post]
2 Mar 2012, 6:52 am
Merck (Vioxx) Trial2006-05-08 Doherty v. [read post]
24 May 2007, 10:40 am
Eddins & Lee Bus Sales, Inc., 491 So.2d 942, 944 (Ala. 1986); Jones v. [read post]
11 Jan 2008, 9:00 am
: (IP Spotlight)PharmaIndia: Trade mark assignment under scrutiny in a case of deceptive similarity - Doctor Morepen Limited v Yash Pharma Laboratories Limited: (Mondaq),Arrow v Merck - An early route to market for generics? [read post]
5 Jun 2013, 5:29 am
Oct. 24, 1996) Merrell Dow Pharms., Inc. v. [read post]
18 Apr 2008, 2:00 am
Lélos Kai Sia EE (and Others) v GlaxoSmithKline AEVE: (IPKat), US: Bio commends Sen Specter for patent reform stance: (Patent Docs), US: USPTO rules on two of four neural stem cell patents in dispute between StemCells Inc and Neuralstem Inc; parties disagree on how extensively claims amended: (IP Law360), (IPBiz), US: Insmed continues fight for generic biologic approval: (GenericsWeb), Pharma & Biotech - Products Cipralex (Escitalopram)… [read post]
25 Apr 2015, 11:03 am
., citing Ofer Shpilberg, et al., The Next Stage: Molecular Epidemiology, 50 J. [read post]
8 Feb 2008, 7:00 pm
– Facebook’s contractual rights to users’ photos problematic: (Spicy IP)PharmaEuropean Commission probes pharmaceutical sector: (Philip Brooks),WHO Board sets course on IP, avian flu, tighter publication policy: (Intellectual Property Watch),India: The Competition Act, patents and over hyped drugs: (Part I - Spicy IP), (Part II – Spicy IP), (Part III – Spicy IP),Ignoring not the solution –… [read post]
30 May 2008, 9:09 am
You can separately subscribe to the IP Thinktank Global week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: WHO members near accord on global strategy on IP and health: (Intellectual Property Watch), (GenericsWeb), (Gowlings), (IAM), Copiepresse seeks up to €49 million from Google in lawsuit over right to feature links to publishers’ content on internet: (IPKat), (Ars Technica), (Techdirt), (Out-Law), (IP Law360) Singapore ‘image… [read post]
